Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Covid-19 vaccines from Moderna and BioNTech/Pfizer have been shown to work against the B.1.1.7 variant in laboratory tests....
...The management team also includes Ian Osborne, a former partner at DST Global, whose investments include Alibaba, Airbnb and Facebook, and Tony Bates, who serves on the boards of eBay, VMware and GoPro....
...Roche and Pfizer, two of the world’s biggest drugmakers, have deals with 23andMe to tap its data for use in research....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The government is under pressure to support the life sciences industry after decisions by Pfizer, AstraZeneca and Novartis to close big UK research and development centres over the past two years with the...
...Steve Bates, chief executive of the UK Bioindustry Association, pointed to promising UK biotech companies such as Circassia and GW Pharmaceuticals as proof of life outside Big Pharma....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Duflo is wearing trousers and a V-necked magenta sweater, with a thin gold chain around her neck. As she speaks, she sometimes thrusts her hands into the opposing sleeves, as if wearing muffs....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition